Insider: Raykov Rosty Director - FENNEC PHARMACEUTICALS INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 51,086 | 0 | 51,086 |
| Value | $461,817.44 | $0.00 | $461,817.44 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/04/2025 | DDS | 10,000 | Direct | COM | $8.92 | $89,200.00 | 51,086 |
| 08/05/2025 | DDS | 10,000 | Direct | COM | $8.09 | $80,900.00 | 55,878 |
| 07/03/2025 | DDS | 10,000 | Direct | COM | $8.61 | $86,100.00 | 60,670 |
| 06/05/2025 | DDS | 10,000 | Direct | COM | $7.78 | $77,800.00 | 65,462 |
| 05/16/2025 | DDS | 16,667 | Direct | COM | $6.78 | $113,002.26 | 70,254 |
| 05/05/2025 | DDS | 10,000 | Direct | COM | $6.31 | $63,100.00 | 53,587 |
| 04/04/2025 | DDS | 10,000 | Direct | COM | $5.25 | $52,500.00 | 61,156 |
| 03/05/2025 | DDS | 10,000 | Direct | COM | $6.79 | $67,900.00 | 68,725 |
| 02/05/2025 | DDS | 10,000 | Direct | COM | $6.66 | $66,600.00 | 76,294 |
| 12/05/2024 | DDS | 796 | Direct | COM | $6.04 | $4,807.84 | 66,432 |
| 12/03/2024 | DDS | 1,635 | Direct | COM | $6.13 | $10,022.55 | 67,228 |
| 11/04/2024 | DDS | 2,431 | Direct | COM | $4.31 | $10,477.61 | 66,432 |
| 09/04/2024 | DDS | 2,431 | Direct | COM | $5.52 | $13,419.12 | 66,432 |
| 08/01/2024 | DDS | 2,431 | Direct | COM | $6.26 | $15,205.91 | 187,471 |
| 07/02/2024 | DDS | 2,431 | Direct | COM | $6.13 | $14,902.03 | 187,471 |
| 06/03/2024 | DDS | 2,431 | Direct | COM | $6.76 | $16,433.56 | 187,471 |
| 05/01/2024 | DDS | 2,431 | Direct | COM | $9.11 | $22,152.00 | 187,471 |
| 04/05/2024 | DDS | 44,300 | Direct | COM | $10.75 | $476,269.30 | 187,471 |
| 04/04/2024 | DDS | 14,583 | Direct | COM | $10.89 | $158,871.58 | 261,471 |
| 04/04/2024 | DDS | 29,700 | Direct | COM | $10.89 | $323,528.04 | 231,771 |
| 04/03/2024 | DDS | 14,584 | Direct | COM | $10.78 | $157,189.27 | 302,054 |
| 04/03/2024 | DDS | 26,000 | Direct | COM | $10.78 | $280,261.80 | 276,054 |
| 04/01/2024 | AAP | 29,167 | Direct | COM | $0.00 | $0.00 | 316,638 |
| 12/28/2023 | DDS | 3,656 | Direct | COM | $11.55 | $42,226.80 | 287,471 |
| 11/08/2023 | DDS | 17,049 | Direct | COM | $7.69 | $131,106.81 | 290,582 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research